Whitehawk Therapeutics Inc share price logo

Whitehawk Therapeutics Inc Share Price

NASDAQ: WHWK

Small Cap

$3.59

as on

Whitehawk Therapeutics Inc Stock Performance

as on March 21, 2026 at 6:58 am IST

  • Day's Low

    Day's High

    $3.40
    $3.67
    downward going graph

    5.29%

    Downside

    2.23%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.39
    $4.48
    downward going graph

    61.28%

    Downside

    24.79%

    Upside

    downward going graph

Whitehawk Therapeutics Inc share price movements today

Previous Close
$3.59
Open
$3.58
Volume
471.3K
Day's Low - High
$3.40 - $3.67
52 Week Low - High
$1.39 - $4.48

Whitehawk Therapeutics Inc Historical Returns

1 Month Return
+ 17.7 %
3 Month Return
+ 40.23 %
1 Year Return
+ 75.12 %
3 Year Return
0 %
5 Year Return
0 %

Whitehawk Therapeutics Inc Stock Fundamentals & Key Indicators

Check Whitehawk Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$169.4M

EPS (TTM)

-1.16

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-21.82%

Whitehawk Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Whitehawk Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$169.4MNANA-288.26%
BUY$41.3B116.54%133.528.45%
BUY$116.3B110.08%29.9432.94%
NA$32.5BNA114.935.37%
BUY$78.0B54.71%17.831.41%

Stock Returns calculator for Whitehawk Therapeutics Inc Stock including INR - Dollar returns

The Whitehawk Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Whitehawk Therapeutics Inc investment value today

Current value as on today

₹1,84,567

Returns

₹84,567

(+84.57%)

Returns from Whitehawk Therapeutics Inc Stock

₹75,122 (+75.12%)

Dollar Returns*

₹9,445 (+9.44%)

Whitehawk Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Whitehawk Therapeutics Inc Stock has increased by 170% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:170% versus previous 30 day period

Whitehawk Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
5
6
5
6
7
7
7
-
-
-
Gross Profit
-6
-7
-8
-7
-3
-7
6
0
0
0
Operating Income
-17
-17
-19
-15
-13
-18
-15
-54
-19
-24
EBITDA
-17
-17
-19
-15
-10
-18
-15
-52
-17
-24
Interest Expense
0
0
0
0
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
-16
-18
-14
-12
-18
73
-52
-17
-23
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-16
-16
-18
-14
-12
-18
73
-52
-17
-23
Net Profit Margin
-273.57%
-257.18%
-341.66%
-236.01%
-173.96%
-252.42%
1021.92%
0.00%
0.00%
0.00%

Whitehawk Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
14
1
15
24
25
7
Gross Profit
-10
0
-18
-18
-27
-28
6
Operating Income
-12
-2
-111
-62
-71
-67
-114
EBITDA
-12
-2
-36
-58
-71
-64
-114
Interest Expense
0
0
0
0
0
0
-
Depreciation
-
0
0
0
0
0
0
Income Before Tax
-12
-3
-110
-60
-65
-63
-20
Income Tax Expense
0
0
0
-
-
-
-
Net Income
-12
-3
-110
-60
-65
-63
-20
Net Profit Margin
-1636.19%
-23.85%
-9829.46%
-397.69%
-270.04%
-245.13%
-288.26%

Whitehawk Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-16
-18
-14
-12
-18
73
-52
-17
-23
Operating Cash Flow
-9
-19
-9
-15
-15
-11
-52
-15
-17
Investing Cash Flow
3
10
-3
5
13
115
-28
-91
16
Financing Cash Flow
0
0
0
-
0
95
0
-
0
Change in Cash
-5
-9
-12
-10
-1
198
-82
-107
0

Whitehawk Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-3
-110
-60
-65
-63
-20
Operating Cash Flow
-12
-22
-49
-59
-59
-97
Investing Cash Flow
-
25
-132
83
25
11
Financing Cash Flow
1
141
72
0
0
94
Change in Cash
-11
144
-109
23
-34
8

Insights on Whitehawk Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, WHWK stock has moved up by 17.7%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, WHWK has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Whitehawk Therapeutics Inc has experienced a drawdown of -50.2%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 47.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -17.74M → -23.25M (in $), with an average decrease of 31.0% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 7.23M → 7.14M (in $), with an average decrease of 1.3% per quarter

About Whitehawk Therapeutics Inc

Whitehawk Therapeutics, Inc., formerly Aadi Bioscience, Inc., is a preclinical stage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Its advanced three-asset antibody drug conjugate (ADC) portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. Its assets include HWK-007, HWK-016 and HWK-206. HWK-007 represents a differentiated opportunity to potentially be among the first next-wave ADCs in clinical development for high PTK7-expressing cancers. HWK-016 is the first ADC that targets the membrane-bound portion of MUC16, a glycoprotein often overexpressed in cancers of female origin. HWK-016 is being evaluated in IND-enabling studies. HWK-206 is designed to address the neuronal target, SEZ6, which is often overexpressed in cancers of neuroendocrine origin.
OrganisationWhitehawk Therapeutics Inc
Headquarters2 Headquarters Plaza, Morristown, NJ, United States, 07960
CEODr. David J. Lennon Ph.D.
E-voting on sharesClick here to vote

Key Management of Whitehawk Therapeutics Inc

Name

Title

Mr. Bryan Ball

Chief Technical Operations Officer

Dr. David Dornan Ph.D.

Chief Scientific Officer

Mr. Stephen M. Rodin J.D.

Senior VP of Legal & General Counsel

Dr. Margaret Han Dugan M.D.

Chief Medical Officer

Dr. David J. Lennon Ph.D.

President, CEO & Director

Dr. Neil P. Desai Ph.D.

Founder & Director

Mr. Scott M. Giacobello CPA

CFO, Treasurer, Investor Relations & Corporate Communications

FAQs

What is Whitehawk Therapeutics Inc share price today?

Whitehawk Therapeutics Inc share price today is $3.59 as on at the close of the market. Whitehawk Therapeutics Inc share today touched a day high of $3.67 and a low of $3.4.

What is the 52 week high and 52 week low for Whitehawk Therapeutics Inc share?

Whitehawk Therapeutics Inc share touched a 52 week high of $4.48 on and a 52 week low of $1.39 on . Whitehawk Therapeutics Inc stock price today i.e. is closed at $3.59,which is 19.86% down from its 52 week high and 158.27% up from its 52 week low.

What is Whitehawk Therapeutics Inc's market capitalisation today?

Whitehawk Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Whitehawk Therapeutics Inc Stock (WHWK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Whitehawk Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Whitehawk Therapeutics Inc Shares that will get you 0.4178 shares as per Whitehawk Therapeutics Inc share price of $3.59 per share as on March 21, 2026 at 1:28 am IST.

What is the minimum amount required to buy Whitehawk Therapeutics Inc Stock (WHWK) from India?

Indian investors can start investing in Whitehawk Therapeutics Inc (WHWK) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Whitehawk Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Whitehawk Therapeutics Inc share’s latest price of $3.59 as on March 21, 2026 at 1:28 am IST, you will get 2.7855 shares of Whitehawk Therapeutics Inc. Learn more about fractional shares .